# US 2024/0266072 A1 · System and method for genomic analysis of pathogens

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0266072 A1
- Document ID: US20240266072A1
- Status: Published application
- Kind: A1
- Application number: 18/563,060
- Filed: 2022-05-21
- Published: 2024-08-08
- Earliest claimed: 2021-05-21
- Assignees: Battelle Memorial Institute
- Applicants: Battelle Memorial Institute
- Inventors: Craig M. Bartling; Brett R. Fowle; Omar P. Tabbaa
- Web page: https://patentgrep.com/patent/US20240266072A1

## CPC

- G16H 50/80: for detecting, monitoring or modelling epidemics or pandemics, e.g. flu
- G16B 20/20: Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
- G16B 30/10: Sequence alignment; Homology search
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY

## Abstract

The present invention is directed towards a bioinformatic method for screening complex patient-derived samples for predicting and identifying at least one pathological agent, especially human pathological agents, comprising establishing agent confidence value from a set of collected patient-derived samples.

## Claims

### Claim 1

A method to identify or to predict a pathological agent, comprising:
a) receiving a dataset of metagenomes from uninfected people or nonhuman animals;
b) receiving an infected dataset;
c) developing a database of clinically relevant proteomes by processing the dataset of metagenomes and the infected dataset;
d) aligning datasets using an aligner tool;
e) removing alignments with less than 99% identity and an alignment length of less than 48 bps;
f) scoring the retained alignments;
g) calculating an agent confidence value from the scoring;
h) predicting an agent based on a confidence threshold; and
i) calculating a performance metric relative to data from a pre-existing method of predicting a disease outbreak.

### Claim 2 (depends on 1)

The method of claim 1 wherein the infected dataset in step b) is developed by converting FastQ and fna datasets into Fasta files.

### Claim 3 (depends on 1)

The method of claim 1 wherein the aligner tool is a lambda aligner.

### Claim 4 (depends on 1)

The method of claim 1, wherein the scoring in step d) is Sa,r,acc produced from:
S
a
,
r
,
acc
=
Rcov
acc
,
r
×
Nuacc
a
n
Na
r
m
×
Nacc
r
p
,
where Rcovacc,r is a measure alignment quality of the query subsequence associated with region r to subject accession acc, Nuaccan is the number of unique accession associated with an agent found across the entire metagenomic sample, Nar is the number of unique agents associated with region r, Naccr is the number of accessions associated with region r, and m, n, and p belong to the integers.

### Claim 5 (depends on 1)

The method as recited in claim 1, wherein the scoring in step g) is Sa,r,acc produced from:
S
a
,
r
,
acc
=
Rcov
acc
,
r
Na
r
×
Nacc
r
wherein Rcovacc,r is a measure alignment quality of the query subsequence associated with region r to subject accession acc, Nar is the number of unique agents associated with the subject accessions in the region r, and Naccr is the number of accessions from the subject database that associates with the region.

### Claim 6 (depends on 1)

The method of claim 1, wherein the agent confidence value in step g) is produced from:
a) obtaining an agent region score, Sa,r, which is calculated to be the score associated with the highest scoring accession for the given agent, region combination:
S
a
,
r
=
max
acc
S
a
,
r
,
acc
;
b) obtaining an agent score, Sa, which is calculated as follows:
S
a
=
∑
r
S
a
,
r
;
and
c) obtaining an agent confidence, Ca, which is defined as:
C
a
=
S
a
∑
a
⁢
S
a
.

### Claim 7 (depends on 6)

The method of claim 6, wherein the agent confidence value in step g) is further obtained by an iterative process comprising:
a) sorting the agents from highest to lowest agent confidence;
b) pulling all regions that are associated with the highest confidence agent;
c) setting the agent, region score equal to zero for all other agents in these regions;
d) recalculating agent confidences;
e) pulling all regions associated with the next highest confidence agent;
f) setting the agent, region score equal to zero for all other agents in these regions; and
g) recalculating agent confidences.
wherein steps e)-g) are repeated until all remaining agents have been iterated over.

### Claim 8 (depends on 1)

The method of claim 1, wherein the confidence threshold is produced based on a training data or wherein an optional K-means clustering of the agent scores by domain can be calculated and the final taxonomies are those associated with the top cluster within each domain (within a threshold).

### Claim 9 (depends on 1)

The method as recited in claim 1, wherein the performance metric in step h) is calculated as precision and recall from:
Precision
=
TP
TP
+
FP
⁢
and
⁢
Recall
=
TP
TP
+
FN
.
such that TP=true positive, TN=true negative, FP=false positive, and FN=false negative; and TP, TN, FP and FN are calculated by comparing the set of predicted agents from step 8) to a set of verified agents from published literatures.

### Claim 10 (depends on 1)

A method of detecting a disease outbreak, comprising:
a) establishing a cohort of individuals for repeated collection of samples;
b) repeatedly collecting samples from the individuals in the cohort;
c) analyzing the samples to identify at least one pathological agent according to claim 1; and
d) determining whether the identified at least one pathological agent indicate a disease outbreak.

### Claim 11 (depends on 10)

The method of claim 10, wherein the cohort of individuals comprises consenting patients such as front line workers, dialysis patients, other immunocompromised patients, or another selected cohort.

### Claim 12 (depends on 10)

The method of claim 10, wherein step b) further comprises sequencing the samples using high throughput screening.

### Claim 13 (depends on 1)

The method as recited in claim 1, wherein the pathological agent is identified in view of a curated data collection comprises at least 1600 proteomes from clinically relevant pathological agents.

### Claim 14 (depends on 10)

The method of claim 10, further comprising transmitting an alert indicating the disease outbreak.

### Claim 15

A method for making a taxonomic composition prediction, comprising:
a) an alignment step against a subject database of protein and/or nucleotide sequences;
b) a filtering step comprising removing low quality alignments;
c) scoring step comprising:
scoring sequence level taxonomy predictions based on an information content; combining sequence-level taxonomy prediction scores into sample-level taxonomy scores;
d) a finding step comprising finding all reads associated with the highest scoring taxonomy that has not yet been processed and removing all other taxonomies and associated accession from the reads; and
wherein the scoring step results in one or more sample-level taxonomy scores; and conducting a K-means cluster of the sample-level taxonomy scores by domain and set the taxonomies associated with a top cluster to a final taxonomic composition prediction.

### Claim 16 (depends on 15)

The method of claim 15, wherein step b) includes anomalous reads.

### Claim 17 (depends on 15)

The method of claim 15, wherein the sequence-level taxonomy prediction scoring in step c) is achieved by Sa,r,acc produced from:
S
a
,
r
,
acc
=
Rcov
acc
,
r
×
Nuacc
a
n
Na
r
m
×
N
acc
r
p
,
where Rcovacc,r is a measure alignment quality of the query subsequence associated with region r to subject accession acc, Nuaccan is the number of unique accession associated with an agent found across the entire metagenomic sample, Nar is the number of unique agents associated with region r, Naccr is the number of accessions associated with region r, and m, n, and p belong to the integers.

### Claim 18 (depends on 15)

The method as recited in claim 15, wherein the sequence-level taxonomy prediction scoring in step c) is achieved by Sa,r,acc produced from:
S
a
,
r
,
acc
=
Rcov
acc
,
r
Na
r
×
Nacc
r
wherein Rcovacc,r is a measure alignment quality of the query subsequence associated with region r to subject accession acc, Nar is the number of unique agents associated with the subject accessions in the region r, and Naccr is the number of accessions from the subject database that associates with the region.

### Claim 19 (depends on 15)

The method of claim 15, wherein in step c) the sample-level taxonomy scores are achieved by:
a) obtaining a taxonomic composition region score, Sa,r, which is calculated to be the score associated with the highest scoring accession for the given taxonomic composition, region combination:
S
a
,
r
=
max
acc
S
a
,
r
,
acc
;
b) obtaining sample-level taxonomy score, Sa, which is calculated as follows:
S
a
=
∑
r
S
a
,
r

### Claim 20 (depends on 15)

The method as recited by claim 15 wherein step 4) further includes iteratively repeating scoring until all taxonomies have been processed.

### Claim at position 21

21-25. (canceled)
